Driving cancer beyond the brink

A new class of drugs aims to exploit cancer cells’ weaknesses

By —— Bio and Archives--October 18, 2017

Health and Medicine | Comments | Print Friendly | Subscribe | Email Us

In recent years, new cancer treatments have brought hope to people who once had limited options. But for others, the wait for an effective drug continues. Now on the horizon is a new generation of drugs based on a concept called synthetic lethality. The cover story in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, takes stock of what’s in the pipeline.

C&EN Senior Correspondent Lisa M. Jarvis explains that researchers have long recognized the vulnerability of cancer cells with broken genes. The idea behind synthetic lethality is that if just one more key gene in those cells were knocked out, cancer cells would be killed, while healthy ones would survive. Building on this concept, drug companies have gained approval for a new class of drugs called PARP inhibitors to treat ovarian cancer. Interest in the strategy has also driven the investment of hundreds of millions of dollars in new biotech firms.

But questions remain over how effective synthetic lethality will be in the long run. The firms are identifying initial drug targets to test, but those targets were selected based on screening cell lines. Whether drugs attacking these targets will work in real tumors remains to be seen. Further testing over the next few years could yield some answers.

Driving cancer beyond the brink

Please SHARE this story as the only way for CFP to beat Facebook anti-Conservative Suppression.

Only YOU can save CFP from Social Media Suppression. Tweet, Post, Forward, Subscribe or Bookmark us

American Chemical Society -- Bio and Archives | Comments

American Chemical Society, ACS is a congressionally chartered independent membership organization which represents professionals at all degree levels and in all fields of chemistry and sciences that involve chemistry.

Commenting Policy

Please adhere to our commenting policy to avoid being banned. As a privately owned website, we reserve the right to remove any comment and ban any user at any time.

Comments that contain spam, advertising, vulgarity, threats of violence, racism, anti-Semitism, or personal or abusive attacks on other users may be removed and result in a ban.
-- Follow these instructions on registering: